Cancer remains one of the most pressing global health challenges. As medical science continues to evolve, new technologies are reshaping how we understand prevention, diagnosis and care. Against this backdrop, China and Europe bring distinct strengths in medical innovation, clinical practice and healthcare systems. In this CGTN roundtable, Professor Sandra Strauss from University College London Hospitals stresses that collaboration is essential in advancing cancer research, especially for rare cancers like squamous cell carcinoma.